Is there a true "shift" to the right colon in the incidence of colorectal cancer?

American Journal of Gastroenterology

Volumn 98, Issue 6, 2003, Pages 1400-1409

  Rabeneck, Linda ^a,b   Davila, Jessica A ^a   El Serag, Hashem B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SCREENING; CANCER STATISTICS; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX RATIO;

EID: 0037973484     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(03)00227-2     Document Type: Article

References (31)

1. American Cancer Society. Cancer facts and figures. Atlanta, GA: American Cancer Society, 2002.
2. Rabeneck L, El-Serag HB, Davila JA, Sandler RS. Outcomes of colorectal cancer in the US: No change in survival (1986-1997). Am J Gastroenterol 2003;98:471-77.
3. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
4. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
5. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
6. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
7. Selby JV, Friedman GD, Quesenberry CP, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
8. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
9. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer: A case-control study among veterans. Arch Intern Med 1995;155:1741-8.
10. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904-10.
11. Winawer SJ, Flehinger BJ, Schottenfeld D, et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993;85:1311-8.
12. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
13. Winawer SJ, Fletcher RH, Rex D, et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale -Update based on new evidence. Gastroenterology 2003;124:544-60.
14. US Preventive Services Task Force. Screening for colorectal cancer: Recommendation and rationale. Ann Intern Med 2002;137:129-31.
15. McLeod R, with the Canadian Task Force on Preventive Health Care. Screening strategies for colorectal cancer: Systematic review and recommendations. CTFPHC Technical Report #01-2. London, Ontario, Canada: Canadian Task Force, 2001.
16. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: Results after 13 years and seven biennial screening rounds. Gut 2002;50:29-32.
17. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-60.
18. Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med 2000;342:1766-72.
19. Mamazza J, Gordon PH. The changing distribution of large intestinal cancer. Dis Colon Rectum 1982;25:558-62.
20. Kee F, Wilson RH, Gilliland R, et al. Changing site distribution of colorectal cancer. BMJ 1992;305:158.
21. Cooper GS, Yuan Z, Landefeld S, et al. A national population-based study of incidence of colorectal cancer and age. Cancer 1995;75:775-81.
22. Cucino C, Buchner AM, Sonnenberg A. Continued rightward shift of colorectal cancer. Dis Colon Rectum 2002;45:1035-40.
23. Surveillance, Epidemiology, and End Results (SEER) program public-use CD-ROM (software) (1973-1997). Bethesda, MD: National Cancer Institute, 2000.
24. Department of Health and Human Services. The international classification of diseases, 9th Revision, Clinical Modification, ICD-9-CM, 3rd ed, Vol. 1. Diseases: Tabular list. DHHS publication no. PHS 89-1260. Washington, DC: Government Printing Office, March 1989.
25. Percy C, Van Holten V, Muir C, eds. International classification of diseases for oncology, 2nd ed. Geneva, Switzerland: World Health Organization, 1990.
26. Kahn HA, Sempos CT. Statistical methods in epidemiology, Vol. 12 of Monographs in epidemiology and biostatistics. New York, NY: Oxford University Press, 1989:87-95.
27. Nelson RL, Persky V, Turyk M. Time trends in distal colorectal cancer subsite location related to age and how it affects choice of screening modality. J Surg Oncol 1998;69:235-8.
28. Dubrow R, Johansen C, Skov T, Holford TR. Age-period-cohort modeling of large-bowel-cancer incidence by anatomic sub-site and sex in Denmark. Int J Cancer 1994;58:324-9.
29. Thom M, Bergstrom R, Kressner U, et al. Trends in colorectal cancer incidence in Sweden 1959-93 by gender, localization, time period, and birth cohort. Cancer Causes and Control 1998;9:145-52.
30. Centers for Disease Control and Prevention. Screening for colorectal cancer - United States, 1997. MMWR 1999;48:116-21.
31. Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med 2000;342:1960-8.